Faced with increasing demands on demonstrating cost effectiveness, pharmaceutical companies are required to conduct pharmacoeconomic evaluations throughout... Hughes,A D.,Walley,... - 《Pharmacoeconomics》 被引量: 35发表: 2001年 A model of the role of free drug samples in physicians' prescription ...
Moving on to the tasks you face in your current role, what are the major challenges facing the pharmaceutical industry today?The article shares the views of Sherry Knowles, senior vice president of corporate intellectual property (IP) and the worldwide head of IP at GlaxoSmithKline, on the ...
PBMs were initially created to reduce drug costs by negotiating prices with pharmaceutical manufacturers. In the late 1980s and early 1990s, these companies worked by pooling purchasing power and leveraging it to the benefit of healthcare consumers. It didn’t take long, however, until...
Pharmaceutical companies in the United States face enormous barriers to entry, including difficulties in achieving Food and Drug Administration (FDA) approval, high research and development (R&D) costs, and intellectual property challenges.2 Recent studies estimate it costs on average $2.8 billion f...
Biotech has one advantage to make up for the cost disadvantage: While pharmaceuticals generally hold exclusive rights to manufacture and distribute their drugs for five years, biotech can get patent protection for as many as 12 years.10 Major pharmaceutical companies have a steady flow ...
Pharmaceutical companies are reaping vast profits without adequate independent scrutiny of their scientific claims.33The purpose of regulators is not to dance to the tune of rich global corporations and enrich them further; it is to protect the health of their populations. We ...
any product sold by pharmaceutical companies that requires refrigeration must be shipped in refrigerated containers. Unlike produce, which is considered a seasonal commodity, pharmaceuticals are a constantly moving product in the supply chain. Regardless of the time of year, you can always expect p...
In pharma manufacturing, sterility and correct dosage are very important. Because of this, the actual filling of the pharmaceutical product on vials, syringes or blister packages is a highly critical part of the manufacturing process. Fill finish has historically been an area with a focus on “pr...
Director, PwC Consulting. Before joining PwC, he worked at a strategy consulting firm. As an Account Lead for a major pharmaceutical company in Japan, he is leading from strategy formulation to implementation support for company-wide transformation on a global level, starting with DX. He is also...
There are currently more than 200 major pharmaceutical companies. As in some other industries, economic pressures are forcing pharmaceutical companies toward greater efficiency. The costs of research and manufacture of ever more sophisticated medicines grows every year and the tension between the affordabil...